Amgen Surpasses Q4 Earnings Forecasts

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.Biotechnology specialist Amgen (AMGN 0.05%) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS of $5.08 and revenue of$8.88 billion, but Amgen reported $5.31 in EPS and$9.1 billion in revenue, showcasing double-digit year-on-year growth in both metrics. Overall, the quarter demonstrated Amgen's eff ...